HEZPROLVI Trademark

Trademark Overview


On Monday, August 19, 2024, a trademark application was filed for HEZPROLVI with the United States Patent and Trademark Office. The USPTO has given the HEZPROLVI trademark a serial number of 98704969. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, January 22, 2025. This trademark is owned by Pfizer Inc.. The HEZPROLVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
hezprolvi

General Information


Serial Number98704969
Word MarkHEZPROLVI
Filing DateMonday, August 19, 2024
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, January 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Trademark Events


Event DateEvent Description
Monday, August 19, 2024NEW APPLICATION ENTERED
Monday, August 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Thursday, October 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, January 22, 2025ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, January 22, 2025ABANDONMENT - AFTER PUBLICATION